import newsCCDC from '../assets/news/News_CCDC.png';
import newsMolecular from '../assets/news/News_Molecular.png';
import newsSymposium from '../assets/news/News_Symposium.png';
import newsCancerPlan from '../assets/news/News_CancerPlan.png';

export const newsList = [
    {
        id: 'ccdc',
        title: 'Childhood Cancer Data Catalog April Update ',
        date: 'APRIL 19, 2023',
        slug: 'The Childhood Cancer Data Catalog is pleased to announce an April update which includes 1 new resource, 8 new datasets, and many other data updates.',
        content: 'The <a href="https://datacatalog.ccdi.cancer.gov/" target="_blank" rel="noopener noreferrer">Childhood Cancer Data Catalog</a> is pleased to announce an April update which includes 1 new resource, 8 new datasets, and many other data updates.This update includes the addition of the Xena Browser, a powerful online exploration tool that allows users to investigate functional genomic data sets for correlations between genomic and/or phenotypic variables, as a new analytic tool resource.  Additionally, 7 new datasets have been incorporated into 8 existing resources. Explore the Catalog to check out all the changes.',
        fullText: '',
        type: 'Application Updates',
        img: newsCCDC,
    },
    {
        id: 'molecular',
        title: 'Molecular characterization results returned to more than 1,000 participants ',
        date: 'APRIL 5, 2023',
        slug: 'The CCDI Molecular Characterization Initiative reached 1K children, adolescents, and young adults (AYAs) newly diagnosed with certain types of cancer.',
        content: 'The <a href="https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/data-ecosystem/molecular-characterization?cid=eb_govdel" target="_blank" rel="noopener noreferrer">CCDI Molecular Characterization Initiative</a> (MCI) achieved a significant milestone in March, enrolling over 1,000 newly diagnosed children, adolescent, and young adults (AYAs) with certain types of cancer. This milestone means that over 1,000 eligible patients now have access to more precise diagnoses, which can aid healthcare providers in planning their treatment.',
        fullText: '<p>The <a href="https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/data-ecosystem/molecular-characterization?cid=eb_govdel" rel="noreferrer noopener" target="_blank">CCDI Molecular Characterization Initiative</a> (MCI) achieved a significant milestone in March, enrolling over 1,000 newly diagnosed children, adolescent, and young adults (AYAs) with certain types of cancer. This milestone means that over 1,000 eligible patients now have access to more precise diagnoses, which can aid healthcare providers in planning their treatment.&nbsp;</p><p>Enrollment continues, free of charge, for children and AYAs newly diagnosed with central nervous system tumors, soft tissue sarcomas, and rare tumors who are receiving care from a Children&rsquo;s Oncology Group&ndash;affiliated hospital.&nbsp;</p><p>MCI data&mdash;excluding personal details that identify participants&mdash;will continue to be released monthly, giving researchers an opportunity to '
        +'learn more about what drives various cancers, develop better clinical trials, and develop more effective treatments for childhood cancer.&nbsp;</p> <p>To join at this time, a child or AYA must:&nbsp;</p><ul><li><p>be newly diagnosed (have not had any treatments for their cancer yet)&nbsp;</p></li><li><p>be 25 years old or younger&nbsp;</p></li><li><p>be diagnosed with a central nervous system tumor (tumors of the brain and spine), soft tissue sarcoma, or rare tumor* (childhood cancers with a low number of patients, which have been hard to study and understand)&nbsp;</p></li><li><p>get cancer care from a hospital affiliated with the Children&rsquo;s Oncology Group&nbsp;</p></li></ul><p>If a child or AYA meets the above criteria, they can get more information on how to participate by talking with their Children &#39;s Oncology Group&ndash;affiliated doctor. &nbsp</p>',
        type: 'Application Updates',
        img: newsMolecular,
    },
    {
        id: 'symposium',
        title: '2023 CCDI Symposium ',
        date: 'APRIL 4, 2023',
        slug: 'The CCDI Annual Symposium, hosted by NCI on March 24, 2023, brought together over 800 members of the research, clinical, survivor, and family communities.',
        content: 'The Childhood Cancer Data Initiative Annual Symposium, hosted by NCI on March 24, 2023, brought together over 800 members of the research, clinical, survivor, and family communities. The event focused on the potential of enhanced data connection and sharing to address current challenges and opportunities in childhood cancer research.',
        fullText: '<p>On March 24, 2023, NCI hosted the <a href="https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/past-symposiums" rel="noreferrer noopener" target="_blank">Childhood Cancer Data Initiative Annual Symposium</a>. Researchers, clinicians, survivors, and families from the community gathered to discuss how enhanced data connection and sharing can address current issues and possibilities in childhood cancer research. Dialogue between speakers and attendees, both virtual and in-person, celebrated CCDI&#39;s accomplishments to date and identified challenges and priorities that lie ahead.  Highlights included discussion of linking patients to disparate data sets, using tumor genomic data to create precision oncology clinical trials, extracting data from electronic health records, and other topics important for the pediatrics cancer community.&nbsp;</p>'
        +'<p>Following the symposium, six breakout sessions were held to continue the symposium&rsquo;s discussion:&nbsp;</p><ol start="1"><li><p>Molecular Characterization Initiative and the potential for future cohort studies&nbsp;</p></li></ol><ol start="2"><li><p>Patient and family perspectives on computable consent and CCDI Participant Index&nbsp;</p></li></ol><ol start="3"><li><p>Electronic health record data extraction: current status and continuing challenges&nbsp;</p></li></ol><ol start="4"><li><p>External controls for pediatric cancer clinical trials&nbsp;</p></li></ol><ol start="5"><li><p>Collaborations and transformative research opportunities using data available through the CCDI ecosystem&nbsp;</p></li></ol><ol start="6"><li><p>Observational studies and novel interventional approaches for rare pediatric cancers&nbsp;</p></li></ol>'
        +'<p><a href="https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/symposium-0" rel="noreferrer noopener" target="_blank">View the event presentation</a> and <a href="https://videocast.nih.gov/watch=49171" rel="noreferrer noopener" target="_blank">watch the recording</a>.&nbsp;</p>',
        type: 'News & Other',
        img: newsSymposium,
    },
    {
        id: 'national_cancer_plan',
        title: 'National Cancer Plan',
        date: 'APRIL 3, 2023',
        slug: 'National Cancer Institute released the National Cancer Plan to engage the broadest possible community to work together to end cancer as we know it.',
        content: 'National Cancer Institute (NCI) has released a <a href="https://nationalcancerplan.cancer.gov/?cid=eb_govdel_allstaff_ncp" target="_blank" rel="noopener noreferrer">National Cancer Plan</a>, a long-term, ambitious framework to end cancer as we know it. The Plan represents a coordinated national response to achieve the goals of the <a href="https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative" target="_blank" rel="noopener noreferrer">Cancer Moonshot</a> and deliver better cancer outcomes to all people.',
        fullText: '',
        type: 'News & Other',
        img: newsCancerPlan,
    },
]